Frankfurt - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.F)
12.76
-0.01
(-0.12%)
As of 8:17:59 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 14 | 14 | 17 | 17 |
Avg. Estimate | 6.04M | 4.78M | 20.63M | 109.34M |
Low Estimate | -- | -- | -- | 9.56M |
High Estimate | 50M | 34.55M | 138.2M | 284.12M |
Year Ago Sales | -- | -- | -- | 20.63M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 429.87% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
4DN.F | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
Maintains | B of A Securities: Buy to Buy | 5/19/2025 |
Maintains | Baird: Outperform to Outperform | 5/8/2025 |
Maintains | Wedbush: Outperform to Outperform | 5/7/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 5/7/2025 |
Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
Reiterates | B. Riley Securities: Buy to Buy | 3/5/2025 |